Annapolis Ballroom 1/2

This session will discuss the evolving regulatory landscape for OTC derivatives, including the compliance requirements relating to the new reporting obligations in connection with OTC derivatives. The panel will also discuss the legal issues and recent developments involving OTC derivatives, with particular focus on issues involving bankruptcies and credit-related issues. Topics will include a discussion of the termination events caused by bankruptcies and the applicability of ISDA protocols for various credit-related events, as well as treatment of market interruption events.

Moderators:
Maria Chiodi, Director & Counsel, Legal & Compliance, Credit Suisse Securities
Susan Ervin, Partner, Dechert

Speakers:
Warren Davis, Of Counsel, Sutherland
Kenneth Kopelman, Partner, Bingham McCutchen
Christopher Ramsay, Director & Associate General Counsel, Citadel Investment Group
Lauren Teigland-Hunt, Managing Partner, Teigland-Hunt
David Van Wagner, Chief Counsel, DMO, Commodity Futures Trading Commission